“…Acquired HLH/MAS complicates diverse, mostly viral, infections, malignancies, autoimmune and autoinflammatory disorders ( Brisse et al., 2016a ), and treatment with chimeric antigen receptor (CAR) T cells ( Neelapu et al., 2018 ). Five of six candidate genes at the major 3p21.31 risk locus for severe COVID-19 ( Ellinghaus et al., 2020 ; Nakanishi et al, 2021 ; Pairo-Castineira et al., 2021 ) point toward DC-T cell interactions ( Kaser, 2020 ), remarkable as that hyperinflammation shares features with HLH/MAS, including hemophagocytosis ( Lucas et al., 2020 ; Prieto-Pérez et al., 2020 ). It remains unclear why excessive T cell activation by FAMIN-impaired DCs results in enhanced immunosurveillance of tumors but fails to control IAV infection.…”